Literature DB >> 9039581

Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission.

P Hauff1, T Fritzsch, M Reinhardt, W Weitschies, F Lüders, V Uhlendorf, D Heldmann.   

Abstract

RATIONALE AND
OBJECTIVES: A new ultrasound contrast agent (SH U 563 A), consisting of hollow biodegradable polymeric microparticles, and a new imaging technique (stimulated acoustic emission) were used for delineation of experimental liver tumors. After intravenous injection, these microparticles are phagocytosed by cells of the reticuloendothelial system (RES) and create a color-coded signal using color Doppler. Because of the different distribution of phagocytic cells in healthy liver tissue and tumors, the delineation of focal lesions was to be tested.
METHODS: Sixteen rabbits with VX2 liver tumors received doses of 0.15-mL SH U 563 A per kilogram of body weight intravenously. Liver investigations (UM9, HD1, L10.5, ATL, Bothell, USA) were performed in vivo before and after SH U 563 A application in B and color Doppler modes. Additionally, the liver and spleen of these rabbits were examined ex vivo in color Doppler. The sonographic diagnosis was confirmed by pathology.
RESULTS: After application of SH U 563 A, the healthy liver tissue of all rabbits was characterized by a typical mosaic color pattern in vivo and ex vivo, using color Doppler. Entire VX2 liver tumors were detectable exclusively in color Doppler after SH U 563 A application. This was possible in 14 of 16 rabbits in vivo and in all 16 livers ex vivo. Furthermore, all ex vivo investigated spleens were color enhanced homogeneously. Sonographic diagnoses were in accordance with pathologic findings.
CONCLUSIONS: SH U 563 A, combined with stimulated acoustic emission, provides potential for delineation of small isoechogenic liver lesions by sonography.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039581     DOI: 10.1097/00004424-199702000-00004

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  9 in total

Review 1.  [Possible target specific molecular imaging with ultrasound contrast agents].

Authors:  M Mäurer; R Linker; M Reinhardt; P Hauff
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

Review 2.  Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma.

Authors:  Hitoshi Maruyama; Masaaki Ebara
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

Review 3.  Microbubble ultrasound contrast agents: an update.

Authors:  Emilio Quaia
Journal:  Eur Radiol       Date:  2007-03-10       Impact factor: 5.315

4.  Experimental investigation and theoretical modelling of the nonlinear acoustical behaviour of a liver tissue and comparison with a tissue mimicking hydrogel.

Authors:  Sergio Casciaro; Christian Demitri; Francesco Conversano; Ernesto Casciaro; Alessandro Distante
Journal:  J Mater Sci Mater Med       Date:  2007-08-01       Impact factor: 3.896

5.  Contrast enhanced ultrasound of hepatocellular carcinoma.

Authors:  Kazushi Numata; Wen Luo; Manabu Morimoto; Masaaki Kondo; Yosuke Kunishi; Tomohiko Sasaki; Akito Nozaki; Katsuaki Tanaka
Journal:  World J Radiol       Date:  2010-02-28

6.  Pharmaceutical evaluation of gas-filled microparticles as gene delivery system.

Authors:  Stefanie Seemann; Peter Hauff; Marcus Schultze-Mosgau; Cathleen Lehmann; Regina Reszka
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

7.  Assessment of hepatic VX(2) tumors with combined percutaneous transhepatic lymphosonography and contrast-enhanced ultrasonographic imaging.

Authors:  Cun Liu; Ping Liang; Yang Wang; Pei Zhou; Xin Li; Zhi-Yu Han; Shao-Ping Liu
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

8.  Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images.

Authors:  Tatsuo Inoue; Masatoshi Kudo; Ryousuke Watai; Zhou Pei; Toshihiko Kawasaki; Yasunori Minami; Hobyung Chung; Toyokazu Fukunaga; Kazuo Awai; Osamu Maenishi
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 6.772

9.  Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.

Authors:  Eun-A Kim; Kwon-Ha Yoon; Young Hwan Lee; Hye Won Kim; Seon Kwan Juhng; Jong Jin Won
Journal:  Korean J Radiol       Date:  2003 Oct-Dec       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.